Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregg Blevins

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
BMC Neurology|April 23, 2015
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disabilityAshley D Radomski, Christopher Power, Scot E Purdon, et al.
Journal of the Neurological Sciences|September 2, 2011
Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE studyNicola De Stefano, Maria Pia Sormani, Bettina Stubinski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosisBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 11, 2020
The Clinical Conundrum of Managing Ischemic Stroke in Patients with Immune ThrombocytopeniaAnas Alrohimi, Kaylynn Purdy, Mustafa Alqarni, et al.
Archives of Neurology|April 15, 2009
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosisBibiana Bielekova, Thomas Howard, Amy N Packer, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 19, 2016
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational StudyLuanne M Metz, Jamie Greenfield, Ruth Ann Marrie, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 3, 2024
MR Susceptibility Separation for Quantifying Lesion Paramagnetic and Diamagnetic Evolution in Relapsing-Remitting Multiple SclerosisZiyan Zhu, Nashwan Naji, Javad Hamidi Esfahani, et al.
Neurology|December 6, 2012
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentaryDaniel Selchen, Virender Bhan, Gregg Blevins, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 18, 2021
Sarcoidosis: a prospective observational cohort from Northern AlbertaDilini Vethanayagam, Jillian Peters, Emad Saad, et al.
Neuroimage|December 3, 2014
Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matterHongfu Sun, Andrew J Walsh, R Marc Lebel, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
BMC Neurology|April 23, 2015
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disabilityAshley D Radomski, Christopher Power, Scot E Purdon, et al.
Journal of the Neurological Sciences|September 2, 2011
Efficacy and safety of subcutaneous interferon β-1a in relapsing-remitting multiple sclerosis: further outcomes from the IMPROVE studyNicola De Stefano, Maria Pia Sormani, Bettina Stubinski, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 25, 2009
Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosisBibiana Bielekova, Nancy Richert, Thomas Howard, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 11, 2020
The Clinical Conundrum of Managing Ischemic Stroke in Patients with Immune ThrombocytopeniaAnas Alrohimi, Kaylynn Purdy, Mustafa Alqarni, et al.
Archives of Neurology|April 15, 2009
Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosisBibiana Bielekova, Thomas Howard, Amy N Packer, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|February 19, 2016
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational StudyLuanne M Metz, Jamie Greenfield, Ruth Ann Marrie, et al.
Journal of Magnetic Resonance Imaging : JMRI|February 3, 2024
MR Susceptibility Separation for Quantifying Lesion Paramagnetic and Diamagnetic Evolution in Relapsing-Remitting Multiple SclerosisZiyan Zhu, Nashwan Naji, Javad Hamidi Esfahani, et al.
Neurology|December 6, 2012
MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentaryDaniel Selchen, Virender Bhan, Gregg Blevins, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 18, 2021
Sarcoidosis: a prospective observational cohort from Northern AlbertaDilini Vethanayagam, Jillian Peters, Emad Saad, et al.
Neuroimage|December 3, 2014
Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matterHongfu Sun, Andrew J Walsh, R Marc Lebel, et al.
Pageof 5